21.8 C
New York
Monday, June 15, 2026

Tag: activities

newssourceFORcompanyinformationcontent1marketreleases

Trilogy Metals Announces Commencement of 2026 Summer Field Program at the Upper Kobuk Mineral Projects in Alaska

VANCOUVER, BC, June 9, 2026 /CNW/ - Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) ("Trilogy Metals", "Trilogy" or the "Company") announced today that field...

Trilogy Metals Announces Commencement of 2026 Summer Field Program at the Upper Kobuk Mineral Projects in Alaska

VANCOUVER, BC, June 9, 2026 /PRNewswire/ - Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) ("Trilogy Metals", "Trilogy" or the "Company") announced today that field...

P2 Gold Gabbs Project Update: Feasibility Study on Track

VANCOUVER, BC, June 9, 2026 /CNW/ - P2 Gold Inc. ("P2" or the "Company") (TSXV: PGLD) (OTCQB: PGLDF) provides an update on the activities underway...

voco™ Scenia Bay Nha Trang Celebrates Global Wellness Day, International Yoga Day and an Invitation to The Show

NHA TRANG, Vietnam, June 9, 2026 /PRNewswire/ -- This June, voco™ Scenia Bay Nha Trang by IHG invites guests to discover a fresh approach...

EHang Reports First Quarter 2026 Unaudited Financial Results

GUANGZHOU, China, June 09, 2026 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading advanced air mobility (“AAM”) technology platform company, today announced its unaudited financial results for the first quarter ended March 31, 2026.

ASE Technology Holding Co., Ltd. Announces Monthly Net Revenues*

TAIPEI, June 9, 2026 /PRNewswire/ -- ASE Technology Holding Co., Ltd. (NYSE: ASX, TWSE: 3711, "ASEH" or the "Company"), announces its unaudited consolidated net...

Progress on share buyback programme

Progress on share buyback programme

Notice of Convening the Annual General Meeting of Shareholders of Arco Vara AS

NOTICE OF THE ANNUAL GENERAL MEETING, ITS AGENDA AND PROPOSED RESOLUTIONS

Rapid Nutrition Featured on CNBC Discussing Key Trends Shaping the Future of Consumer Wellness

CNBC interview explores GLP-1 weight loss adoption, clinically backed nutrition, preventative health and the evolving consumer wellness landscape 
CNBC interview explores GLP-1 weight loss adoption, clinically backed nutrition, preventative health and the evolving consumer wellness landscape

IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants

SOUTH SAN FRANCISCO, Calif., June 8, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA) today announced the pricing of an underwritten public offering of common...

Zepp Health Corporation Reports First Quarter of 2026 Unaudited Financial Results

MILPITAS, Calif., June 8, 2026 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited financial results for the...

AICPA and CIMA Launch Rise2040

A global vision and platform shaping the finance and accounting profession's future through trust, technology, and human-led transformationKUALA LUMPUR, Malaysia, June 9, 2026 /PRNewswire/...

1911 Gold Announces Overnight Marketed Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, June 8, 2026 /CNW/ - 1911 Gold...

Ascendis to Showcase Advances in Treatment of Rare Endocrine Diseases at ENDO 2026

COPENHAGEN, Denmark, June 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its Endocrinology Rare Disease programs in hypoparathyroidism, achondroplasia, and pediatric growth hormone deficiency will be shared in two oral presentations and three posters at ENDO 2026, the annual meeting of the Endocrine Society being held in Chicago from June 13-16, 2026.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsActivities

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers